Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metabolic disorders
Biotech
UPDATE: Lilly-backed metabolic disease biotech files IPO
After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to debut on the public markets.
Gabrielle Masson
Sep 4, 2024 10:23am
Marea ropes in $190M for clinical-stage cardiometabolic program
Jun 18, 2024 7:00am
Arrowhead RNAi med lowers triglycerides in phase 3
Jun 3, 2024 9:54am
Arch-backed obesity biotech launches with $290M
Apr 18, 2024 7:00am
ACC: Efficacy ticks down a smidge for Ionis' metabolic drug
Apr 7, 2024 9:45am
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
